Recent News

By Category: Countermeasures

Novavax Initiates Animal Testing of H7N9 VLP Vaccine

(GlobalBiodefense) Novavax, Inc. this week announced it has completed purification of a virus-like particle (VLP) vaccine candidate for the emerging H7N9 influenza and has initiated animal immunogenicity and efficacy studies.

May 13, 2013
| Filed under North America and Countermeasures
Share

Lyme disease vaccine shows promise in clinical trial

(ScienceDaily) The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International Inc., a U.S. based healthcare company, revealed it to be promising and well tolerated.

May 13, 2013
| Filed under North America and Countermeasures
Share

Medicago Produces VLP Vaccine Candidate for Emerging H7N9 Virus

(GlobalBiodefense) Medicago Inc., a biopharmaceutical company focused on developing vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), this week announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China. “To our knowledge, Medicago is the first to produce Read More »

May 10, 2013
| Filed under Asia/Pacific, North America, and Countermeasures
Share

New antiviral treatment could significantly reduce global burden of hepatitis C

(EurekAlert) Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) – a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. 1 New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the Read More »

May 7, 2013
| Filed under Asia/Pacific, Europe, Countermeasures, Public Health, and Research
Share

DARPA Seeks Innovative Biodefense, Counter-WMD Proposals

(GlobalBiodefense) The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative research proposals of interest to defense and national security. Unconventional approaches that are outside the mainstream are sought, undertaking directions that challenge assumptions and have the potential to radically change established practice.